Malignant melanoma with osteosarcomatous differentiation in a lymph node metastasis by Saleh, Jasmine et al.
CA S E R E POR T
Malignant melanoma with osteosarcomatous differentiation in
a lymph node metastasis
Jasmine Saleh1 | Michael L. Wang2 | Paul W. Harms2,3 | Rajiv M. Patel2,3 |
Douglas R. Fullen2,3
1Department of Otolaryngology-Head and
Neck Surgery, University of Michigan, Ann
Arbor, Michigan
2Department of Pathology, University of
Michigan, Ann Arbor, Michigan
3Department of Dermatology, University of
Michigan, Ann Arbor, Michigan
Correspondence
Dr Douglas R. Fullen, Department of
Pathology, University of Michigan, 3261
Medical Sciences I, 1301 Catherine Road, Ann
Arbor, MI 48109-5602.
Email: dfullen@med.umich.edu
Osteocartilaginous differentiation in malignant melanoma is rare and can pose a diagnostic chal-
lenge. In previously reported cases, melanomas were predominantly located on acral and muco-
sal sites, with osteocartilaginous differentiation present in either primary or recurrent lesions.
We report a case of a 52-year-old female with malignant melanoma located on the right upper
back exhibiting osteosarcomatous differentiation only in the axillary lymph node metastasis. This
case serves to highlight that the divergent differentiation can occur in lymph node metastases
while being absent in the primary lesion. The patient's medical history, careful histological exam-
ination, and immunohistochemistry may be necessary for establishing the correct diagnosis.
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1 | INTRODUCTION
Malignant melanoma may exhibit divergent differentiation. Reported
types of heterologous elements observed in melanoma include fibro-
blastic/myofibroblastic, Schwannian and perineurial, smooth muscle,
rhabdomyosarcomatous, osteocartilaginous, ganglionic and ganglio-
neuroblastic, neuroendocrine, and epithelial.1 Osteocartilaginous dif-
ferentiation of malignant melanoma is very rare, with only 38 cases
being previously reported.2–29 The heterologous elements were
mostly present in the primary or recurrent lesions, but seen only in
the cutaneous metastases in 2 cases and in the lymph node metasta-
ses in 2 other cases.6,9,17,25 These metastases displayed cartilaginous/
chondrosarcomatous differentiation. Rhabdomyosarcomatous differ-
entiation has also been reported in metastases, while not being
observed in the primary melanoma.30 We present an extraordinary
case of malignant melanoma of the right upper back with osteosarco-
matous differentiation restricted to the lymph node metastasis.
2 | CASE PRESENTATION
A 52-year-old female with no known history of malignancy presented
with a skin lesion on her right upper back. On physical examination, a
2.5 cm raised, variegated, hyperpigmented skin lesion with irregular
borders was identified (Figure 1). The lesion had been present for
many years and remained asymptomatic until 1 year prior to the initial
biopsy, when it started to itch. The patient reported that it became
tender and blistered 7 months later.
An initial biopsy of the primary skin lesion was performed at an
outside facility and reviewed for patient management in our Multidisci-
plinary Melanoma Clinic. A subsequent excisional biopsy for microsta-
ging was performed at our institution for final melanoma prognostic
parameters. Histological examination of the microstaging specimen
revealed cytologically atypical epithelioid and spindled cells with finely
vesicular chromatin and conspicuous nucleoli within the epidermis and
dermis, consistent with superficial spreading melanoma invasive to
Clark level IV and 1.65 mm Breslow thickness (Figure 2). The mitotic
rate was 5/mm2. There was no lymphovascular invasion, ulceration, or
osteosarcomatous differentiation present within either specimen.
Immunohistochemical staining of the primary tumor demonstrated that
constitutive cells were positive for S-100, HMB-45, MiTF, SOX-10, and
p16. Melan-A, BRAF V600E, and p63 were negative.
A wide local excision and sentinel lymph node biopsy were per-
formed. The sentinel lymph node biopsy revealed a metastatic neo-
plasm with cytomorphology identical to the patient's primary
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melanoma (Figure 3). The tumor was intimately associated with malig-
nant osteoid in keeping with focal osteosarcomatous differentiation.
No cartilaginous differentiation was identified. Malignant cells in the
metastatic lymph node deposit were immunohistochemically positive
for S-100, MiTF, and SOX-10, but failed to express HMB-45, and
Melan-A (Figure 4).
The patient had a completion lymph node dissection of the right
axilla. The patient's American Joint Committee on Cancer stage was
IIIA (T2a, N1, M0). She was subsequently lost to follow-up 1 month
after the lymph node dissection.
3 | DISCUSSION
Metastatic malignant melanoma with osteocartilaginous differentia-
tion has been reported in a very small number of case reports. Diver-
gent heterologous elements have been observed in various primary
locations, including subungual sites of the fingers and toes, mucosal
areas in the nose, mouth, and vagina, and other sites of the body
including, the face, back, and shoulder.1 However, previously reported
cases were predominantly of melanomas from subungual, acral, and
mucosal sites, with osteocartilaginous differentiation present in the
primary or recurrent lesion.1 Our case is extraordinary in that only the
lymph node metastasis revealed osteosarcomatous heterologous
elements, with no evidence of divergent differentiation observed in
the primary lesion in the routine sections examined.
The mechanism of osteosarcomatous differentiation in metastatic
melanoma has not been well characterized. Some cases reported ossi-
fication in melanomas that developed at sites of previous surgical
trauma, suggesting that the divergent differentiation may represent a
reparative response to injury.25 It has also been hypothesized that
melanoma cells undergo mesenchymal metaplasia to form osteosarco-
matous elements.25 In addition, invading melanoma cells in a lymph
node may induce molecular cascades that promote further prolifera-
tion of tumor cells and activate subsequent divergent
differentiation.25
2.5 cm
FIGURE 1 Clinical appearance of residual primary melanoma on the
right upper back following initial biopsy
FIGURE 2 Microstaging excision of melanoma reveals a superficial
spreading melanoma invasive to Clark's level IV and 1.65 mm Breslow




FIGURE 3 Metastatic melanoma (outlined in red) is identified in the
right axillary sentinel lymph node with focal osteosarcomatous
differentiation (A) (H&E, original magnification ×28). High-power
magnifications of melanoma at a distance from the osteoid (B) and
adjacent to the osteoid (C) are shown (H&E, original
magnification ×400)
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Melanomas with osteogenic and/or cartilaginous differentiation
can pose a diagnostic challenge. They can mimic various other tumors,
including metaplastic carcinomas, sarcomas, neuroendocrine tumors,
lymphomas, or germ cell tumors.25 Of the previously reported 38 cases
with osteocartilaginous differentiation, 9 were initially misdiagnosed
as either osteosarcoma,10–12,17,27 chondrosarcoma,19,21,25 or an extra-
osseous osteogenic sarcoma.3 In our case, the absence of primary
bony involvement, adjacent non-osteosarcomatous melanoma in the
metastasis, expression of melanocytic markers by immunohistochem-
istry (eg, S-100, MiTF, and SOX-10), histological examination revealing
identical morphology in a subset of metastatic malignant to those
seen in the primary lesion and foci of osteosarcomatous differentia-
tion supported our final diagnosis.
Distinguishing melanoma with osteosarcomatous differentiation
from osteosarcoma is clinically very significant, as these diseases
require different treatments.19 Furthermore, osteosarcoma rarely
metastasizes to regional lymph nodes and often responds to chemo-
therapy, whereas metastatic melanoma is not typically responsive to
conventional chemotherapy.19 Our findings suggest that melanoma
should be considered in the differential diagnosis for a metastatic
bone-forming malignancy of unknown primary in a patient with a his-
tory of melanoma, regardless of whether osteosarcomatous differenti-
ation was present in the primary tumor. As in our case, demonstration
of melanocytic marker expression may be useful for supporting the
diagnosis of melanoma in such cases. The prognosis of malignant mel-
anoma with osteosarcomatous differentiation remains unknown due
to the small number of reported cases with significant follow-up.25
4 | CONCLUSION
Melanoma with osteosarcomatous differentiation has been documen-
ted in a very small number of cases and may pose a diagnostic chal-
lenge. Melanomas with divergent heterologous elements can mimic
various other tumors that may require different treatments regiments.
Attention to the patient's past medical history and careful histopatho-
logic and immunohistochemical examination of representative patient
specimens will assist in making the correct diagnosis and ensure
appropriate subsequent clinical management.
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FIGURE 4 Osteosarcomatous differentiation is not observed in the
primary lesion (A, H&E) but rather in lymph node metastasis (B, H&E).
There is expression of S-100 (C, D), MiTF (E, F), and SOX-10 (G, H) in
both the primary melanoma and metastasis. Loss of HMB-45 (I, J) is
noted in the metastasis compared to the primary (original
magnification ×152)
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